tiprankstipranks
Trending News
More News >
Capha Pharmaceuticals (FPSUF)
:FPSUF
US Market

Capha Pharmaceuticals (FPSUF) Stock Statistics & Valuation Metrics

Compare
1 Followers

Total Valuation

Capha Pharmaceuticals has a market cap or net worth of $64.00. The enterprise value is $567.50K.
Market Cap$64.00
Enterprise Value$567.50K

Share Statistics

Capha Pharmaceuticals has 64,431,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding64,431,030
Owned by Insiders
Owned by Institutions

Financial Efficiency

Capha Pharmaceuticals’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 485.83%.
Return on Equity (ROE)0.12
Return on Assets (ROA)-39.21
Return on Invested Capital (ROIC)485.83%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee
Profits Per Employee-10.00T>
Employee Count
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Capha Pharmaceuticals is -0.13. Capha Pharmaceuticals’s PEG ratio is -0.01.
PE Ratio-0.13
PS Ratio0.00
PB Ratio-0.02
Price to Fair Value-0.02
Price to FCF-0.14
Price to Operating Cash Flow-0.14
PEG Ratio-0.01

Income Statement

In the last 12 months, Capha Pharmaceuticals had revenue of 0.00 and earned -70.77K in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-50.74K
Pretax Income-70.77K
Net Income-70.77K
EBITDA-50.74K
Earnings Per Share (EPS)0.00

Cash Flow

In the last 12 months, operating cash flow was -63.95K and capital expenditures 0.00, giving a free cash flow of -63.95K billion.
Operating Cash Flow-63.95K
Free Cash Flow-63.95K
Free Cash Flow per Share>-0.01

Dividends & Yields

Capha Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.00
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00

Important Dates

Capha Pharmaceuticals upcoming earnings date is Sep 1, 2025, TBA (Confirmed).
Last Earnings DateMay 28, 2025
Next Earnings DateSep 1, 2025
Ex-Dividend Date

Financial Position

Capha Pharmaceuticals as a current ratio of <0.01, with Debt / Equity ratio of -96.66%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap60.38
Net Debt to EBITDA-11.02
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Capha Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Capha Pharmaceuticals EV to EBITDA ratio is -11.21, with an EV/FCF ratio of -8.01.
EV to Sales0.00
EV to EBITDA-11.21
EV to Free Cash Flow-8.01
EV to Operating Cash Flow-8.01

Balance Sheet

Capha Pharmaceuticals has $1.38K in cash and marketable securities with C$560.07K in debt, giving a net cash position of $558.69K billion.
Cash & Marketable Securities$1.38K
Total DebtC$560.07K
Net Cash$558.69K
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Capha Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score37
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis